- Home
- PTCT vs HHH Comparison
PTCT vs HHH Comparison
Compare PTCT & HHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTCT
- HHH
- Stock Information
- Founded
- PTCT 1998
- HHH 2010
- Country
- PTCT United States
- HHH United States
- Employees
- PTCT N/A
- HHH N/A
- Industry
- PTCT Biotechnology: Pharmaceutical Preparations
- HHH Real Estate Investment Trusts
- Sector
- PTCT Health Care
- HHH Real Estate
- Exchange
- PTCT Nasdaq
- HHH Nasdaq
- Market Cap
- PTCT 4.1B
- HHH 3.3B
- IPO Year
- PTCT 2013
- HHH N/A
- Fundamental
- Price
- PTCT $50.57
- HHH $75.55
- Analyst Decision
- PTCT Buy
- HHH Buy
- Analyst Count
- PTCT 14
- HHH 2
- Target Price
- PTCT $67.14
- HHH $80.50
- AVG Volume (30 Days)
- PTCT 1.5M
- HHH 389.9K
- Earning Date
- PTCT 08-07-2025
- HHH 08-06-2025
- Dividend Yield
- PTCT N/A
- HHH N/A
- EPS Growth
- PTCT N/A
- HHH N/A
- EPS
- PTCT 7.72
- HHH 4.43
- Revenue
- PTCT $1,764,929,000.00
- HHH $1,770,945,000.00
- Revenue This Year
- PTCT $119.89
- HHH N/A
- Revenue Next Year
- PTCT N/A
- HHH $22.53
- P/E Ratio
- PTCT $6.55
- HHH $15.02
- Revenue Growth
- PTCT 96.00
- HHH 80.45
- 52 Week Low
- PTCT $30.41
- HHH $61.41
- 52 Week High
- PTCT $58.38
- HHH $87.77
- Technical
- Relative Strength Index (RSI)
- PTCT 56.09
- HHH 64.56
- Support Level
- PTCT $48.09
- HHH $72.58
- Resistance Level
- PTCT $54.24
- HHH $74.79
- Average True Range (ATR)
- PTCT 2.37
- HHH 1.68
- MACD
- PTCT 0.19
- HHH 0.32
- Stochastic Oscillator
- PTCT 66.83
- HHH 99.39
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.
About HHH Howard Hughes Holdings Inc.
Howard Hughes Holdings Inc owns, manages, and develops commercial, residential, and mixed-use real estate throughout the USA. Its portfolio is strategically positioned to meet and accelerate development based on market demand, resulting in one of the strongest real estate platforms in the country. It operates through four business segments: Operating Assets, MPCs, Strategic Developments and Seaport.